Search

Search Results
Results 831 - 840 of 867 for Chronic fatigue syndrome
  • Drug - 4 Apr 2024
    Consumer Medicine Information (CMI) about Reyataz intended for persons living in Australia.
  • Drug - 14 Feb 2024
    Consumer Medicine Information (CMI) about Bendamustine Viatris (Bendamustine hydrochloride powder for injection vial) intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about TE-Dasatinib intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Dasatinib-Teva intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Minulet intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Azarga (Brinzolamide 10 mg/mL and timolol 5 mg/mL) intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Symtuza (Darunavir/cobicistat/emtricitabine/tenofovir alafenamide) intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Glypressin Solution intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Sprycel intended for persons living in Australia.
  • Drug - 6 Mar 2023
    Consumer Medicine Information (CMI) about Triphasil (Levonorgestrel and Ethinylestradiol Tablets) intended for persons living in Australia.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.